{"id":9326,"date":"2018-11-05T17:19:52","date_gmt":"2018-11-05T15:19:52","guid":{"rendered":"https:\/\/futurehealthbiobank.com\/lv\/?p=9326"},"modified":"2018-11-05T17:19:52","modified_gmt":"2018-11-05T15:19:52","slug":"diabetiskas-pedu-culas-arstesana-ar-transplantetiem-epicord-audiem","status":"publish","type":"post","link":"https:\/\/futurehealthbiobank.com\/lv\/blog\/diabetiskas-pedu-culas-arstesana-ar-transplantetiem-epicord-audiem\/","title":{"rendered":"Diab\u0113tisk\u0101s p\u0113du \u010d\u016blas \u0101rst\u0113\u0161ana ar transplant\u0113tiem EpiCord audiem"},"content":{"rendered":"<h3>Jauns p\u0113t\u012bjums ierosina, ka nabassaites audus k\u0101du dienu var\u0113tu lietot, lai \u0101rst\u0113tu hroniskas, ne\u0101rst\u0113jamas diab\u0113ti\u0137u p\u0113du \u010d\u016blas. EpiCord ir biezas membr\u0101nas produkts, kas rad\u012bts no nabassaites, tas ir izp\u0113t\u012bts un p\u0101rbaud\u012bts k\u0101 ievainojumu noseg\u0161anas forma un \u010d\u016blu \u0101rst\u0113\u0161anas forma.<\/h3>\n<p><!--more--><\/p>\n<p>Diab\u0113ts skar, aptuveni, 23.1 miljonu cilv\u0113ku ASV un 4 miljonus Apvienotaj\u0101 Karalist\u0113. Diab\u0113ta pacientu \u0101rst\u0113\u0161ana 2012. gad\u0101 izmaks\u0101ja 245 miljardus dol\u0101ru, un m\u016bsdien\u0101s \u0161is skaitlis ir pieaudzis par 41%. Diab\u0113ta p\u0113du \u010d\u016blas (DP\u010c) veido noz\u012bm\u012bgu da\u013cu \u0161o izmaksu, jo t\u0101s pastiprina infekciju un amput\u0101cijas risku.<\/p>\n<p>Jaun\u0101kaj\u0101 veiktaj\u0101 p\u0113t\u012bjum\u0101 zin\u0101tnieki sal\u012bdzin\u0101ja dehidr\u0113tas nabassaites allografmas (EpiCord) dro\u0161\u012bbu un efektivit\u0101ti ar standarta algin\u0101ta ievainojumu p\u0101rs\u0113jiem, lai \u0101rst\u0113tu hroniskas DP\u010c. Nesen tika atz\u012bts EpiCord audu un aug\u013ca \u0161\u0137idruma terapeitisko un \u0101rstniec\u012bbas potenci\u0101ls. Tie satur da\u017e\u0101dus biolo\u0123iskos savienojumus, tostarp, kolag\u0113nu, proteoglik\u0101nu un hialuronsk\u0101bi, kas uzlabo atvese\u013co\u0161an\u0101s procesu sare\u017e\u0123\u012btu audu ievainojumu gad\u012bjumos.<\/p>\n<p>\u0160o p\u0113t\u012bjumu veica piedaloties 155 pacientiem 11 ASV slimn\u012bc\u0101s un priv\u0101taj\u0101s kl\u012bnik\u0101s, laika posm\u0101 no 2016. gada augusta l\u012bdz 2018. gada martam. P\u0113t\u012bjum\u0101 tika iesaist\u012bti dal\u012bbnieki, kuri ir vec\u0101ki par 18 gadiem, slimo ar 1. vai 2. tipa diab\u0113tu, un vi\u0146iem ir DP\u010c. P\u0113t\u012bjums ilga 18 ned\u0113\u013cas, tostarp, 12 ned\u0113\u013cas ilga \u0101rst\u0113\u0161anas f\u0101ze un 4 ned\u0113\u013cas &#8211; sekojo\u0161\u0101s p\u0101rbaudes.<\/p>\n<p>12 ned\u0113\u013cu \u0101rst\u0113\u0161anas perioda laik\u0101, 101 pacients sa\u0146\u0113ma ikned\u0113\u013cas EpiCord proced\u016bru, bet 54 sa\u0146\u0113ma standarta ievainojumu terapiju. P\u0113c bie\u017eas att\u012br\u012b\u0161anas un p\u0101rbaud\u0113m, 70% no \u010d\u016bl\u0101m, ko \u0101rst\u0113ja ar EpiCord, piln\u012bb\u0101 tika iz\u0101rst\u0113tas p\u0113c 12 ned\u0113\u013c\u0101m. Savuk\u0101rt, tikai 48% ar algin\u0101tu \u0101rst\u0113t\u0101s \u010d\u016blas sadzija piln\u012bb\u0101. Turkl\u0101t, tiem pacientiem, kuri sa\u0146\u0113ma piem\u0113rotu ievainojuma \u0101rst\u0113\u0161anu (boj\u0101to audu no\u0146em\u0161anu), 96% ar EpiCord \u0101rst\u0113taj\u0101m \u010d\u016bl\u0101m tika iz\u0101rst\u0113tas piln\u012bb\u0101, ja sal\u012bdzin\u0101m ar 48% ar algin\u0101tu \u0101rst\u0113to \u010d\u016blu sadz\u012b\u0161anas r\u0101d\u012bt\u0101ju.<\/p>\n<p>P\u0113t\u012bjuma laik\u0101 netika zi\u0146ots par EpiCord lieto\u0161anas negat\u012bvajiem efektiem, un \u0161ie rezult\u0101ti pozit\u012bvi nor\u0101da, ka t\u0101ds nabassaites produktu k\u0101 EpiCord var dro\u0161i lietot, lai \u0101rst\u0113tu ne\u0101rst\u0113jamas diab\u0113ta p\u0113du \u010d\u016blas.<\/p>\n<p>Atsauces:\u00a0<a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1111\/iwj.13001\">https:\/\/onlinelibrary.wiley.com\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Jauns p\u0113t\u012bjums ierosina, ka nabassaites audus k\u0101du dienu var\u0113tu lietot, lai \u0101rst\u0113tu hroniskas, ne\u0101rst\u0113jamas diab\u0113ti\u0137u p\u0113du \u010d\u016blas. EpiCord ir biezas membr\u0101nas produkts, kas rad\u012bts no nabassaites, tas ir izp\u0113t\u012bts un p\u0101rbaud\u012bts k\u0101 ievainojumu noseg\u0161anas forma un \u010d\u016blu \u0101rst\u0113\u0161anas forma.<\/p>\n","protected":false},"author":25,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-9326","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.7 (Yoast SEO v26.7) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Diab\u0113tisk\u0101s p\u0113du \u010d\u016blas \u0101rst\u0113\u0161ana ar transplant\u0113tiem EpiCord audiem | Future Health Biobank<\/title>\n<meta name=\"description\" content=\"Jauns p\u0113t\u012bjums ierosina, ka nabassaites audus k\u0101du dienu var\u0113tu lietot, lai \u0101rst\u0113tu hroniskas, ne\u0101rst\u0113jamas diab\u0113ti\u0137u p\u0113du \u010d\u016blas. EpiCord ir biezas membr\u0101nas produkts, kas rad\u012bts no nabassaites, tas ir izp\u0113t\u012bts un p\u0101rbaud\u012bts k\u0101 ievainojumu noseg\u0161anas forma un \u010d\u016blu \u0101rst\u0113\u0161anas forma.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/futurehealthbiobank.com\/lv\/blog\/diabetiskas-pedu-culas-arstesana-ar-transplantetiem-epicord-audiem\/\" \/>\n<meta property=\"og:locale\" content=\"lv_LV\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Diab\u0113tisk\u0101s p\u0113du \u010d\u016blas \u0101rst\u0113\u0161ana ar transplant\u0113tiem EpiCord audiem\" \/>\n<meta property=\"og:description\" content=\"Jauns p\u0113t\u012bjums ierosina, ka nabassaites audus k\u0101du dienu var\u0113tu lietot, lai \u0101rst\u0113tu hroniskas, ne\u0101rst\u0113jamas diab\u0113ti\u0137u p\u0113du \u010d\u016blas. EpiCord ir biezas\" \/>\n<meta property=\"og:url\" content=\"https:\/\/futurehealthbiobank.com\/lv\/blog\/diabetiskas-pedu-culas-arstesana-ar-transplantetiem-epicord-audiem\/\" \/>\n<meta property=\"og:site_name\" content=\"Future Health Biobank Latvia\" \/>\n<meta property=\"article:published_time\" content=\"2018-11-05T15:19:52+00:00\" \/>\n<meta name=\"author\" content=\"jwhybrow\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"jwhybrow\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 min\u016btes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/futurehealthbiobank.com\/lv\/blog\/diabetiskas-pedu-culas-arstesana-ar-transplantetiem-epicord-audiem\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/futurehealthbiobank.com\/lv\/blog\/diabetiskas-pedu-culas-arstesana-ar-transplantetiem-epicord-audiem\/\"},\"author\":{\"name\":\"jwhybrow\",\"@id\":\"https:\/\/futurehealthbiobank.com\/lv\/#\/schema\/person\/7232eecb00f5f56f8f268c5ff3db6719\"},\"headline\":\"Diab\u0113tisk\u0101s p\u0113du \u010d\u016blas \u0101rst\u0113\u0161ana ar transplant\u0113tiem EpiCord audiem\",\"datePublished\":\"2018-11-05T15:19:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/futurehealthbiobank.com\/lv\/blog\/diabetiskas-pedu-culas-arstesana-ar-transplantetiem-epicord-audiem\/\"},\"wordCount\":436,\"commentCount\":0,\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"lv-LV\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/futurehealthbiobank.com\/lv\/blog\/diabetiskas-pedu-culas-arstesana-ar-transplantetiem-epicord-audiem\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/futurehealthbiobank.com\/lv\/blog\/diabetiskas-pedu-culas-arstesana-ar-transplantetiem-epicord-audiem\/\",\"url\":\"https:\/\/futurehealthbiobank.com\/lv\/blog\/diabetiskas-pedu-culas-arstesana-ar-transplantetiem-epicord-audiem\/\",\"name\":\"Diab\u0113tisk\u0101s p\u0113du \u010d\u016blas \u0101rst\u0113\u0161ana ar transplant\u0113tiem EpiCord audiem | Future Health Biobank\",\"isPartOf\":{\"@id\":\"https:\/\/futurehealthbiobank.com\/lv\/#website\"},\"datePublished\":\"2018-11-05T15:19:52+00:00\",\"author\":{\"@id\":\"https:\/\/futurehealthbiobank.com\/lv\/#\/schema\/person\/7232eecb00f5f56f8f268c5ff3db6719\"},\"description\":\"Jauns p\u0113t\u012bjums ierosina, ka nabassaites audus k\u0101du dienu var\u0113tu lietot, lai \u0101rst\u0113tu hroniskas, ne\u0101rst\u0113jamas diab\u0113ti\u0137u p\u0113du \u010d\u016blas. EpiCord ir biezas membr\u0101nas produkts, kas rad\u012bts no nabassaites, tas ir izp\u0113t\u012bts un p\u0101rbaud\u012bts k\u0101 ievainojumu noseg\u0161anas forma un \u010d\u016blu \u0101rst\u0113\u0161anas forma.\",\"breadcrumb\":{\"@id\":\"https:\/\/futurehealthbiobank.com\/lv\/blog\/diabetiskas-pedu-culas-arstesana-ar-transplantetiem-epicord-audiem\/#breadcrumb\"},\"inLanguage\":\"lv-LV\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/futurehealthbiobank.com\/lv\/blog\/diabetiskas-pedu-culas-arstesana-ar-transplantetiem-epicord-audiem\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/futurehealthbiobank.com\/lv\/blog\/diabetiskas-pedu-culas-arstesana-ar-transplantetiem-epicord-audiem\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"S\u0101kums\",\"item\":\"https:\/\/futurehealthbiobank.com\/lv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Diab\u0113tisk\u0101s p\u0113du \u010d\u016blas \u0101rst\u0113\u0161ana ar transplant\u0113tiem EpiCord audiem\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/futurehealthbiobank.com\/lv\/#website\",\"url\":\"https:\/\/futurehealthbiobank.com\/lv\/\",\"name\":\"Future Health Biobank Latvia\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/futurehealthbiobank.com\/lv\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"lv-LV\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/futurehealthbiobank.com\/lv\/#\/schema\/person\/7232eecb00f5f56f8f268c5ff3db6719\",\"name\":\"jwhybrow\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"lv-LV\",\"@id\":\"https:\/\/futurehealthbiobank.com\/lv\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c9af53d69103cbfe6f956d3ca06fe15f77fe26760b48a18012d4a05637201dad?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c9af53d69103cbfe6f956d3ca06fe15f77fe26760b48a18012d4a05637201dad?s=96&d=mm&r=g\",\"caption\":\"jwhybrow\"},\"url\":\"https:\/\/futurehealthbiobank.com\/lv\/blog\/author\/jwhybrow\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Diab\u0113tisk\u0101s p\u0113du \u010d\u016blas \u0101rst\u0113\u0161ana ar transplant\u0113tiem EpiCord audiem | Future Health Biobank","description":"Jauns p\u0113t\u012bjums ierosina, ka nabassaites audus k\u0101du dienu var\u0113tu lietot, lai \u0101rst\u0113tu hroniskas, ne\u0101rst\u0113jamas diab\u0113ti\u0137u p\u0113du \u010d\u016blas. EpiCord ir biezas membr\u0101nas produkts, kas rad\u012bts no nabassaites, tas ir izp\u0113t\u012bts un p\u0101rbaud\u012bts k\u0101 ievainojumu noseg\u0161anas forma un \u010d\u016blu \u0101rst\u0113\u0161anas forma.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/futurehealthbiobank.com\/lv\/blog\/diabetiskas-pedu-culas-arstesana-ar-transplantetiem-epicord-audiem\/","og_locale":"lv_LV","og_type":"article","og_title":"Diab\u0113tisk\u0101s p\u0113du \u010d\u016blas \u0101rst\u0113\u0161ana ar transplant\u0113tiem EpiCord audiem","og_description":"Jauns p\u0113t\u012bjums ierosina, ka nabassaites audus k\u0101du dienu var\u0113tu lietot, lai \u0101rst\u0113tu hroniskas, ne\u0101rst\u0113jamas diab\u0113ti\u0137u p\u0113du \u010d\u016blas. EpiCord ir biezas","og_url":"https:\/\/futurehealthbiobank.com\/lv\/blog\/diabetiskas-pedu-culas-arstesana-ar-transplantetiem-epicord-audiem\/","og_site_name":"Future Health Biobank Latvia","article_published_time":"2018-11-05T15:19:52+00:00","author":"jwhybrow","twitter_card":"summary_large_image","twitter_misc":{"Written by":"jwhybrow","Est. reading time":"2 min\u016btes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/futurehealthbiobank.com\/lv\/blog\/diabetiskas-pedu-culas-arstesana-ar-transplantetiem-epicord-audiem\/#article","isPartOf":{"@id":"https:\/\/futurehealthbiobank.com\/lv\/blog\/diabetiskas-pedu-culas-arstesana-ar-transplantetiem-epicord-audiem\/"},"author":{"name":"jwhybrow","@id":"https:\/\/futurehealthbiobank.com\/lv\/#\/schema\/person\/7232eecb00f5f56f8f268c5ff3db6719"},"headline":"Diab\u0113tisk\u0101s p\u0113du \u010d\u016blas \u0101rst\u0113\u0161ana ar transplant\u0113tiem EpiCord audiem","datePublished":"2018-11-05T15:19:52+00:00","mainEntityOfPage":{"@id":"https:\/\/futurehealthbiobank.com\/lv\/blog\/diabetiskas-pedu-culas-arstesana-ar-transplantetiem-epicord-audiem\/"},"wordCount":436,"commentCount":0,"articleSection":["Uncategorized"],"inLanguage":"lv-LV","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/futurehealthbiobank.com\/lv\/blog\/diabetiskas-pedu-culas-arstesana-ar-transplantetiem-epicord-audiem\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/futurehealthbiobank.com\/lv\/blog\/diabetiskas-pedu-culas-arstesana-ar-transplantetiem-epicord-audiem\/","url":"https:\/\/futurehealthbiobank.com\/lv\/blog\/diabetiskas-pedu-culas-arstesana-ar-transplantetiem-epicord-audiem\/","name":"Diab\u0113tisk\u0101s p\u0113du \u010d\u016blas \u0101rst\u0113\u0161ana ar transplant\u0113tiem EpiCord audiem | Future Health Biobank","isPartOf":{"@id":"https:\/\/futurehealthbiobank.com\/lv\/#website"},"datePublished":"2018-11-05T15:19:52+00:00","author":{"@id":"https:\/\/futurehealthbiobank.com\/lv\/#\/schema\/person\/7232eecb00f5f56f8f268c5ff3db6719"},"description":"Jauns p\u0113t\u012bjums ierosina, ka nabassaites audus k\u0101du dienu var\u0113tu lietot, lai \u0101rst\u0113tu hroniskas, ne\u0101rst\u0113jamas diab\u0113ti\u0137u p\u0113du \u010d\u016blas. EpiCord ir biezas membr\u0101nas produkts, kas rad\u012bts no nabassaites, tas ir izp\u0113t\u012bts un p\u0101rbaud\u012bts k\u0101 ievainojumu noseg\u0161anas forma un \u010d\u016blu \u0101rst\u0113\u0161anas forma.","breadcrumb":{"@id":"https:\/\/futurehealthbiobank.com\/lv\/blog\/diabetiskas-pedu-culas-arstesana-ar-transplantetiem-epicord-audiem\/#breadcrumb"},"inLanguage":"lv-LV","potentialAction":[{"@type":"ReadAction","target":["https:\/\/futurehealthbiobank.com\/lv\/blog\/diabetiskas-pedu-culas-arstesana-ar-transplantetiem-epicord-audiem\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/futurehealthbiobank.com\/lv\/blog\/diabetiskas-pedu-culas-arstesana-ar-transplantetiem-epicord-audiem\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"S\u0101kums","item":"https:\/\/futurehealthbiobank.com\/lv\/"},{"@type":"ListItem","position":2,"name":"Diab\u0113tisk\u0101s p\u0113du \u010d\u016blas \u0101rst\u0113\u0161ana ar transplant\u0113tiem EpiCord audiem"}]},{"@type":"WebSite","@id":"https:\/\/futurehealthbiobank.com\/lv\/#website","url":"https:\/\/futurehealthbiobank.com\/lv\/","name":"Future Health Biobank Latvia","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/futurehealthbiobank.com\/lv\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"lv-LV"},{"@type":"Person","@id":"https:\/\/futurehealthbiobank.com\/lv\/#\/schema\/person\/7232eecb00f5f56f8f268c5ff3db6719","name":"jwhybrow","image":{"@type":"ImageObject","inLanguage":"lv-LV","@id":"https:\/\/futurehealthbiobank.com\/lv\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/c9af53d69103cbfe6f956d3ca06fe15f77fe26760b48a18012d4a05637201dad?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c9af53d69103cbfe6f956d3ca06fe15f77fe26760b48a18012d4a05637201dad?s=96&d=mm&r=g","caption":"jwhybrow"},"url":"https:\/\/futurehealthbiobank.com\/lv\/blog\/author\/jwhybrow\/"}]}},"_links":{"self":[{"href":"https:\/\/futurehealthbiobank.com\/lv\/wp-json\/wp\/v2\/posts\/9326","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/futurehealthbiobank.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/futurehealthbiobank.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/futurehealthbiobank.com\/lv\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/futurehealthbiobank.com\/lv\/wp-json\/wp\/v2\/comments?post=9326"}],"version-history":[{"count":0,"href":"https:\/\/futurehealthbiobank.com\/lv\/wp-json\/wp\/v2\/posts\/9326\/revisions"}],"wp:attachment":[{"href":"https:\/\/futurehealthbiobank.com\/lv\/wp-json\/wp\/v2\/media?parent=9326"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/futurehealthbiobank.com\/lv\/wp-json\/wp\/v2\/categories?post=9326"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/futurehealthbiobank.com\/lv\/wp-json\/wp\/v2\/tags?post=9326"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}